Literature DB >> 6345570

Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189).

H J Quabbe, A S Luyckx, M L'age, C Schwarz.   

Abstract

Two chemically unrelated inhibitors of lipolysis were used in order to differentiate between the effect of FFA depression and a possible FFA-unrelated drug effect, respectively, on the plasma concentrations of GH, cortisol, and glucagon. Saline infusion served as a control experiment. In eight healthy male volunteers, a similar FFA depression by either iv infusion of nicotinic acid (3-pyridine-carboxylic acid, NA) or oral intake of an adenosine derivative, N(6)-allyl-N(6)-cyclohexyl-adenosine (AD-D), was followed by a significant GH increase (to 22.1 +/- 6.2 and 9.6 +/- 2.9 ng/ml at 240 and 270 min, respectively). Due to the large scatter of the GH concentrations during NA infusion, these responses were not significantly different. No GH increase occurred when the FFA depression was prevented by addition of a lipid infusion. In contrast, plasma cortisol and glucagon both increased significantly (by 107.4 micrograms/liter at 270 min and by 48.4 pg/ml at 60 min, respectively) during NA- but not during AD-D-induced FFA depression. Addition of the lipid infusion abolished the cortisol increase during NA infusion but had no influence on basal cortisol concentrations during AD-D intake. It lowered glucagon to values slightly below basal concentrations when added to the NA infusion and more markedly during AD-D administration. The results provide evidence that 1) depression of plasma FFA per se stimulates the secretion of GH, and 2) the increase of cortisol and glucagon during NA infusion is probably unrelated to the FFA depression. Hence, the stimulatory effect of FFA lack on glucagon secretion needs to be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345570     DOI: 10.1210/jcem-57-2-410

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  A Fall in plasma free fatty acid (FFA) level activates the hypothalamic-pituitary-adrenal axis independent of plasma glucose: evidence for brain sensing of circulating FFA.

Authors:  Young Taek Oh; Ki-Sook Oh; Insug Kang; Jang H Youn
Journal:  Endocrinology       Date:  2012-06-05       Impact factor: 4.736

Review 2.  Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.

Authors:  Insug Kang; Sang-Wook Kim; Jang H Youn
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 3.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

4.  Hypothalamic control of GH secretion: pathophysiology and clinical implications.

Authors:  H J Quabbe
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

5.  Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats.

Authors:  Tobias Kroon; Ann Kjellstedt; Pia Thalén; Johan Gabrielsson; Nicholas D Oakes
Journal:  J Lipid Res       Date:  2015-07-13       Impact factor: 5.922

6.  Prolonged niacin treatment leads to increased adipose tissue PUFA synthesis and anti-inflammatory lipid and oxylipin plasma profile.

Authors:  Mattijs M Heemskerk; Harish K Dharuri; Sjoerd A A van den Berg; Hulda S Jónasdóttir; Dick-Paul Kloos; Martin Giera; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  J Lipid Res       Date:  2014-10-15       Impact factor: 5.922

7.  A pilot study of the effects of niacin administration on free fatty acid and growth hormone concentrations in children with obesity.

Authors:  O A Galescu; M K Crocker; A M Altschul; S E Marwitz; S M Brady; J A Yanovski
Journal:  Pediatr Obes       Date:  2016-09-21       Impact factor: 4.000

8.  Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B.

Authors:  Mattijs M Heemskerk; Sjoerd A A van den Berg; Amanda C M Pronk; Jan-Bert van Klinken; Mariëtte R Boon; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-28       Impact factor: 4.310

9.  Niacin supplementation increases the number of oxidative type I fibers in skeletal muscle of growing pigs.

Authors:  Muckta Khan; Robert Ringseis; Frank-Christoph Mooren; Karsten Krüger; Erika Most; Klaus Eder
Journal:  BMC Vet Res       Date:  2013-09-09       Impact factor: 2.741

10.  Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats.

Authors:  Aline Couturier; Janine Keller; Erika Most; Robert Ringseis; Klaus Eder
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.